Tackling Affordability with Direct-to-Patient Sales Blog Tackling Affordability with Direct-to-Patient Sales 2025 年 4 月 11 日 Accessing affordable healthcare is one of the biggest challenges U.S. patients face.…Danielle Pillsbury2025 年 4 月 11 日
Write Quicker PBPK Reports with the Simcyp Report Assistant Blog Write Quicker PBPK Reports with the Simcyp Report Assistant 2025 年 4 月 11 日 Writing a report for PBPK models can be an onerous process, especially…Danielle Pillsbury2025 年 4 月 11 日
Delivering DSUR Excellence for Multinational Biopharma Case Study Delivering DSUR Excellence for Multinational Biopharma A global leader in immuno-oncology approached us for support with over 50 simple to complex…Danielle Pillsbury2025 年 4 月 11 日
Model-Based Meta-Analysis (MBMA) for Relative Treatment Effects and Absolute Outcomes: A Focus on Concepts and Applications Webinar Model-Based Meta-Analysis (MBMA) for Relative Treatment Effects and Absolute Outcomes: A Focus on Concepts and Applications 2025 年 5 月 27 日 - 11am ETDanielle Pillsbury2025 年 4 月 10 日
Revolutionizing Medical Writing: AI Accelerates Drug Development Efficiency [Chinese webinar] Webinar Revolutionizing Medical Writing: AI Accelerates Drug Development Efficiency [Chinese webinar] This webinar is available only in Chinese.Artificial intelligence (AI) is revolutionizing drug development at an…Danielle Pillsbury2025 年 4 月 10 日
Certainty US 2025 Live Events Certainty US 2025 2025 年 5 月 7 日 - 8 日 | Philadelphia, PADanielle Pillsbury2025 年 4 月 9 日
How Certara MIDD Experts Overcame Client Regulatory Challenges Case Study How Certara MIDD Experts Overcame Client Regulatory Challenges Certara’s Model-Informed Drug Development (MIDD) approach leverages an integrated, quantitative systems methodology to accelerate regulatory…Danielle Pillsbury2025 年 4 月 8 日
Standardizing Real World Data in Rare Disease: ATHN’s Journey Case Study Standardizing Real World Data in Rare Disease: ATHN’s Journey The American Thrombosis and Hemostasis Network (ATHN), a not-for-profit organization, has been improving care and…Danielle Pillsbury2025 年 4 月 8 日
What’s New in Phoenix 8.6? 网络研讨会 What’s New in Phoenix 8.6? 日期:To be announced | Coming in Q2 2025Solutions: Preclinical, Early Clinical, Late Clinical, RegulatoryProducts:…Danielle Pillsbury2025 年 4 月 7 日
Mechanistic Modeling to Meet Challenges in ADC Development Blog Mechanistic Modeling to Meet Challenges in ADC Development 2025 年 4 月 4 日 Navigating the challenges in antibody-drug conjugates (ADCs) development requires overcoming complex hurdles…Danielle Pillsbury2025 年 4 月 4 日